Kawasaki Disease – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Kawasaki-Disease-Pipeline-Review-H1-2012-215255.html

RSS link of Global Markets Direct

http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Kawasaki Disease - Pipeline Review, H1 2012, provides an overview of the Kawasaki Disease therapeutic pipeline. This report provides information on the therapeutic development for Kawasaki Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Kawasaki Disease. Kawasaki Disease - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Kawasaki Disease.

- A review of the Kawasaki Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 3

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Kawasaki Disease Overview 6

Therapeutics Development 7

An Overview of Pipeline Products for Kawasaki Disease 7

Kawasaki Disease Therapeutics under Investigation by Universities/Institutes 9

Late Stage Products 10

Comparative Analysis 10

Mid Clinical Stage Products 11

Comparative Analysis 11

Early Clinical Stage Products 12

Comparative Analysis 12

Kawasaki Disease Therapeutics – Products under Investigation by Universities/Institutes 13

Kawasaki Disease – Therapeutics Assessment 14

Assessment by Monotherapy Products 14

Assessment by Combination Products 15

Assessment by Route of Administration 16

Assessment by Molecule Type 18

Drug Profiles 20

List of Figures

List of Tables are also include.

For more related Reports Plz follow The link:

Pipeline Review, H1 2012

http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1

Corneal Neovascularization – Pipeline Review, H1 2012

Meningioma – Pipeline Review, H1 2012

Bacterial (Pyogenic) Meningitis – Pipeline Review, H1 2012

Kawasaki Disease – Pipeline Review, H1 2012

Retinopathy – Pipeline Review, H1 2012

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare

http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1

You can also request for sample page of above mention reports on sample@aarkstore.com

For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585